Valuation: Oxford BioDynamics Plc

Market Cap 6.28M 7.25M 5.88M 5.36M 10.09M 691M 10.26M 68.93M 27.01M 346M 27.21M 26.61M 1.15B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 11.18M 12.9M 10.47M 9.55M 17.97M 1.23B 18.28M 123M 48.09M 616M 48.45M 47.39M 2.06B EV / Sales 2026 *
5.97x
EV / Sales 2027 * -
Free-Float
90.13%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Oxford BioDynamics Plc

1 week+40.00%
Current month+40.00%
1 month+40.00%
6 months+75.00%
Current year+150.00%
1 month 0
Extreme 0.0015
0
Current year 0
Extreme 0.0015
0
1 year 0
Extreme 0.0014
0.01
3 years 0
Extreme 0.0014
0.5
5 years 0
Extreme 0.0014
1.25
10 years 0
Extreme 0.0014
1.25
Manager TitleAgeSince
Chief Executive Officer - 2026-06-29
Chief Tech/Sci/R&D Officer 64 2007-06-07
Director of Finance/CFO - 2017-09-14
Director TitleAgeSince
Director/Board Member 64 2007-06-07
Director/Board Member - 2017-09-14
Director/Board Member 65 2019-04-04
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+40.00% - - 6.96M
+0.60%+7.75%-2.11%-26.18% 2.63B
+6.05%+14.74%-0.05%-82.81% 1.81B
+1.43%+8.75%-5.69%-12.19% 350M
+1.80%+5.82%-44.31% - 56.39M
Average +1.98%+13.50%-13.04%-40.39% 1.21B
Weighted average by Cap. +2.71%+20.82%-2.09%-46.58%

Financials

2026 *2027 *
Net sales 1.87M 2.16M 1.75M 1.6M 3.01M 206M 3.06M 20.55M 8.05M 103M 8.11M 7.93M 344M -
Net income - -
Net Debt 4.9M 5.66M 4.59M 4.19M 7.88M 540M 8.01M 53.82M 21.09M 270M 21.24M 20.78M 901M -
Logo Oxford BioDynamics Plc
Oxford BioDynamics Plc is a United Kingdom-based biotechnology company, advancing personalized healthcare by developing and commercializing precision clinical diagnostic tests for life-changing diseases. The Company is primarily engaged in the commercialization of proprietary molecular diagnostics products and biomarker research and development. Its products include EpiSwitch CiRT, EpiSwitch PSE, Specimen Submission Kit, and EpiSwitch Explorer. The EpiSwitch CiRT is a blood test which predicts an individual patient’s therapeutic response to checkpoint inhibitor immunotherapy. The EpiSwitch Explorer is a microarray kit for high-throughput, high-resolution 3D genome profiling. The Specimen Submission Kit is used for collecting samples from any location. The EpiSwitch platform offers reproducibly translating three-dimensional (3D) genome regulation for clinical applications. This platform provides a portfolio of clinical smart tests based on EpiSwitch technology.
Employees
-
Date Price Change Volume
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001250GBP
Average target price
0.0100GBP
Spread / Average Target
+700.00%

Annual profits - Rate of surprise